Soma Das to Antineoplastic Agents
This is a "connection" page, showing publications Soma Das has written about Antineoplastic Agents.
Connection Strength
0.123
-
Oncology drug development in the UK: analysis of the past 25 years and focus on the 2026 reboot of the clinical trial regulatory framework. Br J Cancer. 2026 Oct; 135(8):1286-1297.
Score: 0.110
-
Ancestry and pharmacogenetics of antileukemic drug toxicity. Blood. 2007 May 15; 109(10):4151-7.
Score: 0.007
-
Pharmacogenetics of outcome in children with acute lymphoblastic leukemia. Blood. 2005 Jun 15; 105(12):4752-8.
Score: 0.006